Vladimiras Oleinikovas

Vladimiras Oleinikovas

Auto-generated profile, based on publicly available information

Vladimiras Oleinikovas

Monte Rosa Therapeutics Inc, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2016 in Journal of the American Chemical Society
Verified
Journal Article
Open access
VOVladimiras Oleinikovas
Vladimiras Oleinikovas
GSGiorgio Saladino
Giorgio Saladino
BCBenjamin P. Cossins
Benjamin P. Cossins
FGFrancesco Luigi Gervasio
Francesco Luigi Gervasio
Cryptic pockets, that is, sites on protein targets that only become apparent when drugs bind, provide a promising alternative to classical binding sites for drug development. Here, we investigate the nature and dynamical properties of cryptic sites in four pharmacologically relevant targets, while comparing the efficacy of various simulation-based approaches in discovering them. We find that the studied cryptic sites do not correspond to local minima in the computed conformational free energy landscape of the unliganded proteins. They thus promptly close in all of the molecular dynamics simulations performed, irrespective of the force-field used. Temperature-based enhanced sampling approaches, such as Parallel Tempering, do not improve the situation, as the entropic term does not help in the opening of the sites. The use of fragment probes helps, as in long simulations occasionally it leads to the opening and binding to the cryptic sites. Our observed mechanism of cryptic site formation is suggestive of an interplay between two classical mechanisms: induced-fit and conformational selection. Employing this insight, we developed a novel Hamiltonian Replica Exchange-based method “SWISH” (Sampling Water Interfaces through Scaled Hamiltonians), which combined with probes resulted in a promising general approach for cryptic site discovery. We also addressed the issue of “false-positives” and propose a simple approach to distinguish them from druggable cryptic pockets. Our simulations, whose cumulative sampling time was more than 200 μs, help in clarifying the molecular mechanism of pocket formation, providing a solid basis for the choice of an efficient computational method.

13 October 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JRJoseph M. Rogers
Joseph M. Rogers
VOVladimiras Oleinikovas
Vladimiras Oleinikovas
SSSarah L. Shammas
Sarah L. Shammas
CWChi T. Wong
Chi T. Wong
DSDavid De Sancho
David De Sancho
JCJane Clarke
Jane Clarke
Significance: Specific protein–protein interactions are abundant in, and essential for, cellular life. In contrast to the well-studied docking of two already folded proteins, it has been recently established that many proteins are disordered and unfolded in the absence of their partner protein, but appear folded once bound. Must these initially disordered proteins transiently fold in isolation before binding their partners? We examine a small disordered protein and find that interactions with its (already structured) partner protein are what cause the relatively unstructured protein to fold. Thus, the requirement for one protein to fold is not an obstacle for reliable, fast association between two proteins. This result offers some explanation for the abundance of similar protein–protein interactions throughout biology.

3 July 2025 in Science
Verified
Journal Article
Closed access
GPGeorg Petzold
Georg Petzold
PGPablo Gainza
Pablo Gainza
SAStefano Annunziato
Stefano Annunziato
ILIlaria Lamberto
Ilaria Lamberto
PTPeter Trenh
Peter Trenh
STSharon A. Townson
Sharon A. Townson
The CRL4 CRBN E3 ubiquitin ligase is the target of molecular glue degrader compounds that reprogram ligase specificity to induce the degradation of clinically relevant neosubstrate proteins. Known cereblon (CRBN) neosubstrates share a generalizable β-hairpin G-loop recognition motif that allows for the systematic exploration of the CRBN target space. Computational mining approaches using structure- and surface-based matchmaking algorithms predict more than 1600 CRBN-compatible G-loop proteins across the human proteome, including the newly discovered helical G-loop motif, and identify the noncanonical neosubstrate binding mode of VAV1 that engages CRBN through a molecular surface mimicry mechanism. This work broadens the CRBN target space, redefines rules for neosubstrate recognition, and establishes a platform for the elimination of challenging drug targets by repurposing CRL4 CRBN through next-generation molecular glue degraders.

17 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JDJanani Durairaj
Janani Durairaj
YAYusuf Adeshina
Yusuf Adeshina
ZCZhonglin Cao
Zhonglin Cao
XZXuejin Zhang
Xuejin Zhang
VOVladas Oleinikovas
Vladas Oleinikovas
LNLuca Naef
Luca Naef
Protein-ligand interactions (PLI) are foundational to small molecule drug design. With computational methods striving towards experimental accuracy, there is a critical demand for a well-curated and diverse PLI dataset. Existing datasets are often limited in size and diversity, and commonly used evaluation sets suffer from training information leakage, hindering the realistic assessment of method generalization capabilities. To address these shortcomings, we present PLIN-DER, the largest and most annotated dataset to date, comprising 449,383 PLI systems, each with over 500 annotations, similarity metrics at protein, pocket, interaction and ligand levels, and paired unbound ( apo ) and predicted structures. We propose an approach to generate training and evaluation splits that minimizes task-specific leakage and maximizes test set quality, and compare the resulting performance of DiffDock when retrained with different kinds of splits.

11 February 2021 in eLife
Verified
Journal Article
Open access
AMAlex Macpherson
Alex Macpherson
Maisem LaabeiMaisem Laabei
Maisem Laabei
ZAZainab Ahdash
Zainab Ahdash
MGMelissa A Graewert
Melissa A Graewert
JBJames R Birtley
James R Birtley
Jean van den ElsenJean van den Elsen
Jean van den Elsen
Bovines have evolved a subset of antibodies with ultra-long heavy chain complementarity determining regions that harbour cysteine-rich knob domains. To produce high-affinity peptides, we previously isolated autonomous 3–6 kDa knob domains from bovine antibodies. Here, we show that binding of four knob domain peptides elicits a range of effects on the clinically validated drug target complement C5. Allosteric mechanisms predominated, with one peptide selectively inhibiting C5 cleavage by the alternative pathway C5 convertase, revealing a targetable mechanistic difference between the classical and alternative pathway C5 convertases. Taking a hybrid biophysical approach, we present C5-knob domain co-crystal structures and, by solution methods, observed allosteric effects propagating >50 Å from the binding sites. This study expands the therapeutic scope of C5, presents new inhibitors, and introduces knob domains as new, low molecular weight antibody fragments, with therapeutic potential.

29 November 2017 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
LHLadislav Hovan
Ladislav Hovan
VOVladimiras Oleinikovas
Vladimiras Oleinikovas
HYHavva Yalinca
Havva Yalinca
AKAndriy Kryshtafovych
Andriy Kryshtafovych
GSGiorgio Saladino
Giorgio Saladino
FGFrancesco Luigi Gervasio
Francesco Luigi Gervasio